Checkmate Pharmaceuticals CMPI
$ 10.5
0.0%
Quarterly report 2022-Q1
added 12-23-2023
Checkmate Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CMPI
Annual EV/EBITDA Ratio Checkmate Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-0.0315 | -4.59 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-0.0315 | -4.59 | -2.31 |